The utilization of spitz‐related nomenclature in the histological interpretation of cutaneous melanocytic lesions by practicing pathologists: results from the M‐Path study
Authors:
- 30 September 2016
- journal article
- research article
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 44 (1) , 5-14
Abstract
Background: Spitz nevi, atypical Spitz tumors and spitzoid melanomas (‘spitzoid lesions’) represent controversial and poorly understood cutaneous melanocytic lesions that are difficult to diagnose histologically. It is unknown how these terms are used by pathologists.Methods: We describe use of Spitz‐related terminology using data from the Melanoma Pathology (M‐Path) study database comprising pathologists' interpretations of biopsy slides, a nation‐wide study evaluating practicing US pathologists' (N = 187) diagnoses of melanocytic lesions (8976 independent diagnostic assessments on 240 total test cases, with 1 slide per case).Results: Most pathologists (90%) used the Spitz‐related terminology. However, significant variation exists in which specific lesions were diagnosed as spitzoid and in the corresponding treatment recommendations. Recommendations ranged from ‘no further treatment’ to ‘wide excision of 10 mm or greater’ with no category capturing more than 50% of responses. For spitzoid melanoma diagnoses, 90% of pathologists recommended excision with ≥10 mm margin. Pathologists report less confidence in diagnosing these lesions compared with other melanocytic proliferations and are more likely to request second opinions and additional clinical information (all p < 0.05).Conclusions: Spitzoid lesions are often not classified in any standardized way, evoke uncertainty in diagnosis by pathologists, and elicit variability in treatment recommendations.Keywords
Funding Information
- National Cancer Institute
- National Institutes of Health (R01 CA 151306, K05 CA 104699, 5T32AR056969)
This publication has 23 references indexed in Scilit:
- The MPATH-Dx reporting schema for melanocytic proliferations and melanomaJournal of the American Academy of Dermatology, 2014
- Risk Assessment for Atypical Spitzoid Melanocytic Neoplasms Using FISH to Identify Chromosomal Copy Number AberrationsAmerican Journal of Surgical Pathology, 2013
- Spitz nevi and other Spitzoid lesionsJournal of the American Academy of Dermatology, 2011
- Spitz nevi and other Spitzoid lesionsJournal of the American Academy of Dermatology, 2011
- Melanocytic Tumors of Uncertain Malignant PotentialAmerican Journal of Surgical Pathology, 2010
- The Spitzoid lesion: rethinking Spitz tumors, atypical variants, ‘Spitzoid melanoma' and risk assessmentLaboratory Investigation, 2006
- “Atypical” Blue Nevus, “Malignant” Blue Nevus, and “Metastasizing” Blue Nevus: A Critique in Historical Perspective of Three Concepts Flawed FatallyThe American Journal of Dermatopathology, 2004
- Use of Bayes Rule and MIB-1 Proliferation Index to Discriminate Spitz Nevus From Malignant MelanomaAmerican Journal of Clinical Pathology, 2004
- Use of Bayes Rule and MIB-1 Proliferation Index to Discriminate Spitz Nevus From Malignant MelanomaAmerican Journal of Clinical Pathology, 2004
- Spitz Tumors in ChildrenArchives of Dermatology, 1999